Biomarin Pharmaceutical (BMRN) Net Equity Issued and Repurchased (2009 - 2025)
Biomarin Pharmaceutical (BMRN) reported Net Equity Issued and Repurchased of $6.75 million for Q4 2025, down 14.2% from $7.86 million a year earlier.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Net Equity Issued and Repurchased (2009 - 2025) Analysis & Trends
For FY2025, Biomarin Pharmaceutical posted Net Equity Issued and Repurchased of $14.46 million, down 70.7% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -27.4% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $49.28 million in FY2024 (-28.9%), $69.35 million in FY2023 (unchanged), $69.33 million in FY2022 (+40.9%) and $49.19 million in FY2021 (-31.6%).
- Five-year quarterly Net Equity Issued and Repurchased spans a low of $7,000 in Q3 2025 and a high of $29.42 million in Q2 2024.
- Year over year, Net Equity Issued and Repurchased has now declined in each of the last three quarters, with an average decline of 41.3% over the last seven quarters.
- The high point for year-over-year Net Equity Issued and Repurchased in five years was Q3 2022 (growth of 174.5%); the low point was Q3 2025 (a decline of 99.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 7.71 Mn |
| Dec 31, 2024 | 7.86 Mn |
| Sep 30, 2024 | 4.80 Mn |
| Jun 30, 2024 | 29.42 Mn |
| Mar 31, 2024 | 7.20 Mn |
| Dec 31, 2023 | 14.81 Mn |
| Sep 30, 2023 | 4.36 Mn |
| Jun 30, 2023 | 29.02 Mn |
| Mar 31, 2023 | 21.17 Mn |
| Dec 31, 2022 | 25.47 Mn |
| Sep 30, 2022 | 14.37 Mn |
| Jun 30, 2022 | 21.26 Mn |
| Mar 31, 2022 | 8.24 Mn |
| Dec 31, 2021 | 16.32 Mn |
| Sep 30, 2021 | 5.24 Mn |
| Jun 30, 2021 | 21.82 Mn |
| Mar 31, 2021 | 5.82 Mn |
| Dec 31, 2020 | 11.65 Mn |
API Access
Biomarin Pharmaceutical Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();